225 related articles for article (PubMed ID: 10404100)
1. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).
Beemsterboer PM; Kranse R; de Koning HJ; Habbema JD; Schröder FH
Int J Cancer; 1999 Aug; 84(4):437-41. PubMed ID: 10404100
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
[TBL] [Abstract][Full Text] [Related]
3. Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).
Kranse R; Beemsterboer P; Rietbergen J; Habbema D; Hugosson J; Schröder FH
Prostate; 1999 Jun; 39(4):316-22. PubMed ID: 10344223
[TBL] [Abstract][Full Text] [Related]
4. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).
Roobol MJ; Kirkels WJ; Schröder FH
BJU Int; 2003 Dec; 92 Suppl 2():48-54. PubMed ID: 14983955
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
[TBL] [Abstract][Full Text] [Related]
7. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
[TBL] [Abstract][Full Text] [Related]
8. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
9. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
[TBL] [Abstract][Full Text] [Related]
10. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
[TBL] [Abstract][Full Text] [Related]
12. Screening for prostate cancer without digital rectal examination and transrectal ultrasound: results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; Roemeling S; de Vries SH; Cruijsen-Koeter Iv; van der Kwast TH; Schröder FH;
Prostate; 2006 May; 66(6):625-31. PubMed ID: 16388507
[TBL] [Abstract][Full Text] [Related]
13. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
[TBL] [Abstract][Full Text] [Related]
14. Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy?
Alivizatos G; Deliveliotis C; Mitropoulos D; Raptides G; Louras G; Karayiannis A; Becopoulos T; Dimopoulos AM
Urology; 1996 Dec; 48(6A Suppl):71-5. PubMed ID: 8973704
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.
Bazinet M; Meshref AW; Trudel C; Aronson S; Péloquin F; Nachabe M; Bégin LR; Elhilali MM
Urology; 1994 Jan; 43(1):44-51; discussion 51-2. PubMed ID: 7506853
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy.
Ito K; Ichinose Y; Kubota Y; Imai K; Yamanaka H
Int J Urol; 1997 Sep; 4(5):474-9. PubMed ID: 9354949
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men.
Gustafsson O; Carlsson P; Norming U; Nyman CR; Svensson H
Prostate; 1995 Jun; 26(6):299-309. PubMed ID: 7540297
[TBL] [Abstract][Full Text] [Related]
20. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; Roemeling S; Schröder FH
Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
